[Chemotherapy of melancholia by sequential neuroleptic-viloxazine association].

Abstract

Viloxazine administered as a unique antidepressant may in some cases cause an aggravation of anxiety and agitation or manic states. In order to control this effect, we thought of administering neuroleptics and anxiolytics: 1) Before Viloxazine for a few days. 2) Then during antidepressant treatment. The results were as follow: 1) Quick and efficient upon melancholic states in manic -- depressive psychoses. 2) Irregular and questionable upon other depressions.

• Authors: S Brion, J F Chevalier, R Guerin, D Ginestet
• Journal: L'Encephale (Encephale) Vol. 2 Issue 3 Pg. 257-71 ( 1976) ISSN: 0013-7006 [Print] France
• Vernacular Title: Chimiothérapie de la mélancolie par l'association séquentielle neuroleptique-viloxazine
• PMID: 991806 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Morpholines
• Tranquilizing Agents
• Viloxazine
• Sulpiride
• Methotrimeprazine
• Haloperidol
• Chlorpromazine

Topics

• Adjustment Disorders (drug therapy)
• Adult
• Bipolar Disorder (drug therapy)
• Chlorpromazine (administration & dosage)
• Depression (drug therapy)
• Depressive Disorder, Major (drug therapy)
• Drug Therapy, Combination
• Female
• Haloperidol (administration & dosage)
• Humans
• Male
• Methotrimeprazine (administration & dosage)
• Middle Aged
• Morpholines (administration & dosage)
• Sulpiride (administration & dosage)
• Tranquilizing Agents (administration & dosage)
• Viloxazine (administration & dosage)